Morning Overview on MSN
Experimental Alzheimer’s approach reverses cognitive decline in mice
Researchers have reversed cognitive decline in mice engineered to mimic Alzheimer’s disease, using nanoparticles that repair ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the 'Company”), a healthcare company developing and commercializing precision ...
Roluperidone has been de-risked by consistent positive results in two prior pivotal trials and remains the only late-stage drug candidate for this high-need population Efficacy topline data expected ...
This Research Topic focuses on cancers originating outside the central nervous system across the lifespan (including paediatric, adolescent, and adult ...
Plus Therapeutics, Inc. (the 'Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with ...
FDA assigned PDUFA target action date of September 27, 2026 BOSTON, March 30, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous syst ...
Innervation plays a pivotal role in the development and functional control of tissues and organs, with the vagus nerve ...
A research team led by Professor Dr. Niels Gehring from the Institute for Genetics has shown that the coordinated interaction ...
A new theoretical framework reveals why magnetoelectric nanoparticles behave unpredictably and how their nonlinear physics ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma ” or the “Company ”), a biopharmaceutical ...
How does the gut cause Multiple Sclerosis? New research identifies the MHC II protein in intestinal epithelial cells as the trigger for MS-related neuroinflammation. Discover how gut-primed T cells ...
Multiple sclerosis (MS) is a debilitating neurological disorder caused by malfunctioning immune responses that target the brain and spinal cord of the central nervous system (CNS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results